The phencyclidine model of schizophrenia: basic mechanisms

被引：0
|
作者：
Svensson, TH [1 ]
机构：
[1] Karolinska Inst, Sect Neuropsychopharmacol, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [31] Neonatal phencyclidine as a model of sex-biased schizophrenia symptomatology in adolescent mice
    Dutra-Tavares, Ana Carolina
    Souza, Thaina P.
    Silva, Juliana O.
    Semeao, Keila A.
    Mello, Felipe F.
    Filgueiras, Claudio C.
    Ribeiro-Carvalho, Anderson
    Manhaes, Alex C.
    Abreu-Villaca, Yael
    PSYCHOPHARMACOLOGY, 2023, 240 (10) : 2111 - 2129
  • [32] DOSE DEPENDENT EFFECTS OF ANTIPSYCHOTICS ON BONE MASS IN PHENCYCLIDINE ANIMAL MODEL OF SCHIZOPHRENIA
    Petronijevic, N.
    Nikolic, T.
    Velimirovic, M.
    Jevtic, G.
    Stojkovic, T.
    Petronijevic, M.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S535 - S535
  • [33] Advances in the study of phencyclidine-induced schizophrenia-like animal models and the underlying neural mechanisms
    Li, Dabing
    Pan, Qiangwen
    Xiao, Yewei
    Hu, Kehui
    SCHIZOPHRENIA, 2024, 10 (01)
  • [34] MAGNETIC RESONANCE IMAGING CHARACTERIZATION OF EARLY POSTNATAL PHENCYCLIDINE TREATMENT AS A RAT MODEL OF SCHIZOPHRENIA
    Broberg, Brian V.
    Madsen, Kristoffer H.
    Plath, Niels
    Olsen, Christina K.
    Glenthoj, Birte Y.
    Paulson, Olaf B.
    Bjelker, Borje
    Sogaard, Lise V.
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S94 - S94
  • [35] Effects of Antipsychotics on the Hypothalamus-Pituitary-Adrenal Axis in a Phencyclidine Animal Model of Schizophrenia
    Nikolic, Tatjana
    Bogosavljevic, Milica Velimirovic
    Stojkovic, Tihomir
    Kanazir, Selma
    Loncarevic-Vasiljkovic, Natasa
    Radonjic, Nevena V.
    Popic, Jelena
    Petronijevic, Natasa
    CELLS, 2024, 13 (17)
  • [36] Dose dependent effects of antipsychotics on prolactin and corticosterone concentration in a phencyclidine animal model of schizophrenia
    Nikolic, T.
    Nenadovic, M.
    Jevtic, G.
    Stojkovic, T.
    Velimirovic, M.
    Lazovic, M.
    Zivkovic, M.
    Radonjic, N.
    Petronijevic, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S256 - S257
  • [37] Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment
    Noda, E
    Nabeshima, T
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2000, 120 (08): : 677 - 682
  • [38] Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine
    Reynolds, Gavin P.
    Neill, Joanna C.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (11) : 1141 - 1144
  • [39] PHENCYCLIDINE ACTION ON NEURAL MECHANISMS OF SOMESTHESIS
    ROPPOLO, JR
    WERNER, G
    WHITSEL, BL
    DREYER, DA
    PETRUCELLI, LM
    NEUROPHARMACOLOGY, 1973, 12 (05) : 417 - 431
  • [40] Using hIPSCs to Model Disease Mechanisms in Schizophrenia
    Atkin, Talia
    Qi, Yuchen
    Sun, Ziyi
    Markx, Sander
    Gogos, Joseph
    Tomishima, Mark
    Studer, Lorenz
    Karayiorgou, Maria
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S314 - S315
12345